Mary Willy

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. doi request reprint Emergency department visits attributed to selected analgesics, United States, 2004-2005
    Mary Willy
    Center for Drug Evaluation and Research, FDA, Silver Spring, MD, USA
    Pharmacoepidemiol Drug Saf 18:188-95. 2009
  2. ncbi request reprint Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States
    Parivash Nourjah
    Office of Drug Safety, Division of Drug Risk Evaluation, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993, USA
    Pharmacoepidemiol Drug Saf 15:398-405. 2006
  3. pmc Informatic tools and approaches in postmarketing pharmacovigilance used by FDA
    Joyce Weaver
    Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20903 0002, USA
    AAPS J 10:35-41. 2008

Detail Information

Publications3

  1. doi request reprint Emergency department visits attributed to selected analgesics, United States, 2004-2005
    Mary Willy
    Center for Drug Evaluation and Research, FDA, Silver Spring, MD, USA
    Pharmacoepidemiol Drug Saf 18:188-95. 2009
    ..To estimate the rate of emergency department (ED) visits attributed to selected analgesic-containing medications...
  2. ncbi request reprint Estimates of acetaminophen (Paracetomal)-associated overdoses in the United States
    Parivash Nourjah
    Office of Drug Safety, Division of Drug Risk Evaluation, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993, USA
    Pharmacoepidemiol Drug Saf 15:398-405. 2006
    ..To estimate the number of acetaminophen-associated overdoses in the United States and identify possible risk factors for intervention...
  3. pmc Informatic tools and approaches in postmarketing pharmacovigilance used by FDA
    Joyce Weaver
    Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20903 0002, USA
    AAPS J 10:35-41. 2008
    ..The FDA has implemented a number of initiatives to help identify safety problems with drugs and continues to evaluate their efforts...